April 15, 2011

Whoever named the genus to which ragweed plants belong “ambrosia” had a terrific sense of irony. The name, derived from Greek, refers to the food of the gods, but the plant is more like punishment from the gods, considering that it’s the main culprit in seasonal allergies.

March 7, 2011

An over-the-counter version of the antihistamine Allegra hit the marketplace amid a promotional frenzy that was consistent with the approach taken when such similar products as Claritin and Zyrtec became available without a prescription. As was the case with other products before it, retailers are eager to get their share of sales, so there tends to be considerable activity around the launch.

March 4, 2011

As Drug Store News suggested last month, legislation under consideration in Tennessee and Kentucky that would make the popular decongestant pseudoephedrine only available by prescription has, in fact, sparked interest in neighboring states.

February 18, 2011

PARIS — Allegra is less than a week away from reaching shelves on March 4, and with the latest allergy switch will come a significant number of Rx allergy sufferers this summer.


February 18, 2011

All the hype around H1N1 
that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later.

January 28, 2011

Though Schering-Plough’s — now Merck’s — Claritin and Johnson & Johnson’s Zyrtec product lines have dominated the over-the-counter antihistamine market, the big share of the prescription antihistamine market held by Sanofi-Aventis’ Allegra (fexofenadine hydrochloride) could give it a battering ram to bust in as well, thanks to the big break Sanofi got in the form of a Food and Drug Administration approval of an OTC switch for the drug.

May 16, 2010

As of Feb. 9, Sanofi-Aventis officially entered the self-care solution arena with its acquisition of...

March 18, 2010

Claritin is teaming up with allergy sufferer and "American Idol" judge Kara DioGuardi around a...

June 28, 2009

There was speculation in January that Schering-Plough’s switch application around the proton-pump inhibitor Zegerid was...